Akcea Therapeutics' IPO

Akcea Therapeutics raised a round of funding on July 14, 2017. Investors include Public.

Akcea Therapeutics (NASDAQ: AKCA) is a late-stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid diso…

Articles about Akcea Therapeutics' IPO: